Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FFAR1 | O14842 | 20/20 | 0.69 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13616868 | 1.00 | FFAR1 (0.69) | FFAR1 | |
| SCHEMBL13616752 | 0.92 | FFAR1 (0.58) | FFAR1 | |
| SCHEMBL3853388 | 0.88 | FFAR1 (0.71) | FFAR1 | |
| SCHEMBL3852671 | 0.88 | FFAR1 (0.71) | FFAR1 | |
| SCHEMBL13616862 | 0.88 | FFAR1 (0.71) | FFAR1 | |
| SCHEMBL3859656 | 0.88 | FFAR1 (0.68) | FFAR1 | |
| SCHEMBL13616864 | 0.88 | FFAR1 (0.68) | FFAR1 | |
| SCHEMBL3853358 | 0.87 | FFAR1 (0.65) | FFAR1 | |
| SCHEMBL13616869 | 0.87 | FFAR1 (0.67) | FFAR1 | |
| SCHEMBL3854753 | 0.87 | FFAR1 (0.67) | FFAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5458977-A | Electroluminescence device containing a thin film electrode | IDEMITSU KOSAN CO., LTD. (JP) | 1995-10-17 | — | — | US | claimed |
| US-5231329-A | Organic thin film electroluminescent device | NIPPON OIL CO., LTD. (JP) | 1993-07-27 | — | — | US | claimed |
| US-20090275598-A1 | Conformationally constrained 3-(4-hydroxy-phenyl)-substituted-propanoic acids useful for treating metabolic disorders | AMGEN INC. (US) | 2009-11-05 | — | — | US | disclosed |
| US-20090275598-A1 | Conformationally constrained 3-(4-hydroxy-phenyl)-substituted-propanoic acids useful for treating metabolic disorders | AMGEN INC. (US) | 2009-11-05 | — | — | US | disclosed |
| US-7585574-B2 | Pyrene derivative and organic electroluminescence device making use of the same | IDEMITSU KOSAN CO., LTD. (JP) | 2009-09-08 | — | — | US | disclosed |
| US-7582803-B2 | Conformationally constrained 3-(4-hydroxy-phenyl)-substituted-propanoic acids useful for treating metabolic disorders | AMGEN INC. (US) | 2009-09-01 | — | — | US | disclosed |
| US-7582803-B2 | Conformationally constrained 3-(4-hydroxy-phenyl)-substituted-propanoic acids useful for treating metabolic disorders | AMGEN INC. (US) | 2009-09-01 | — | — | US | disclosed |
| US-20080124571-A1 | PYRENE DERIVATIVE AND ORGANIC ELECTROLUMINESCENCE DEVICE MAKING USE OF THE SAME | IDEMITSU KOSAN CO., LTD. (JP) | 2008-05-29 | — | — | US | disclosed |
| EP-1924546-A1 | CONFORMATIONALLY CONSTRAINED 3- (4-HYDROXY-PHENYL) - SUBSTITUTED-PROPANOIC ACIDS USEFUL FOR TREATING METABOLIC DISORDERS | Amgen, Inc (US) | 2008-05-28 | — | — | EP | disclosed |
| EP-1905754-A1 | PYRENE DERIVATIVE AND ORGANIC ELECTROLUMINESCENCE DEVICE MAKING USE OF THE SAME | IDEMITSU KOSAN CO., LTD. (JP) | 2008-04-02 | — | — | EP | disclosed |
| WO-2007033002-A1 | CONFORMATIONALLY CONSTRAINED 3- (4-HYDROXY-PHENYL) - SUBSTITUTED-PROPANOIC ACIDS USEFUL FOR TREATING METABOLIC DISORDERS | AMGEN INC. (US) | 2007-03-22 | — | — | WO | disclosed |
| EP-1162193-B1 | Acrylenediamine derivatives and organic electroluminescence device containing the same | IDEMITSU KOSAN CO (JP) | 2003-05-14 | — | — | EP | disclosed |
| EP-0721935-B1 | ORGANIC ELECTROLUMINESCENT ELEMENT AND ARYLENEDIAMINE DERIVATIVE | IDEMITSU KOSAN CO (JP) | 2003-01-22 | — | — | EP | disclosed |
| US-6459199-B1 | Multicolor organic EL element having plurality of organic dyes, method of manufacturing the same, and display using the same | CHEMIPRO KASEI KAISHA, LIMITED (JP) | 2002-10-01 | — | — | US | disclosed |
| EP-1162193-A1 | Acrylenediamine derivatives and organic electroluminescence device containing the same | IDEMITSU KOSAN COMPANY LIMITED (JP) | 2001-12-12 | — | — | EP | disclosed |
| US-6284393-B1 | USABLE FOR HIGH-RESOLUTION DISPLAY; LUMINOUS EFFICIENCY, LOW RESISTANCE AND TRANSPARENCY; DURABILITY | IDEMITSU KOSAN CO., LTD. (JP) | 2001-09-04 | — | — | US | disclosed |
| EP-1119221-A2 | Organic electroluminescent device | IDEMITSU KOSAN COMPANY LIMITED (JP) | 2001-07-25 | — | — | EP | disclosed |
| EP-1119222-A2 | Organic electroluminescent device | IDEMITSU KOSAN COMPANY LIMITED (JP) | 2001-07-25 | — | — | EP | disclosed |
| EP-0845924-A2 | Organic electroluminescent device | IDEMITSU KOSAN COMPANY LIMITED (JP) | 1998-06-03 | — | — | EP | disclosed |
| EP-0721935-A1 | ORGANIC ELECTROLUMINESCENT ELEMENT AND ARYLENEDIAMINE DERIVATIVE | IDEMITSU KOSAN COMPANY LIMITED (JP) | 1996-07-17 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090275598-A1 | Conformationally constrained 3-(4-hydroxy-phenyl)-substituted-propanoic acids useful for treating metabolic disorders | PC, PNLIP, PDHX | FFAR1 51/4885 |
| US-20080124571-A1 | PYRENE DERIVATIVE AND ORGANIC ELECTROLUMINESCENCE DEVICE MAKING USE OF THE SAME | PPOX, CYBA, EBPL | FFAR1 4610/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.